{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:17:23Z","timestamp":1762867043692,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.endinu.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T23:21:12Z","timestamp":1561850472000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV\u2013HIV co-infected patients before and after interferon alpha therapy: A prospective study"],"prefix":"10.1016","volume":"67","author":[{"given":"Alicia","family":"Lowenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Fainboim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Lutzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Ameigeiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Schroder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Laura","family":"Eugenio Russmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.endinu.2019.04.012_bib0155","first-page":"154","article-title":"Argentine consensus on hepatitis C 2013","volume":"44","author":"Reggiardo","year":"2014","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"5","key":"10.1016\/j.endinu.2019.04.012_bib0160","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/OLQ.0b013e3181d73c0d","article-title":"Hepatitis B virus, hepatitis C virus and HIV coinfection among people living with HIV\/AIDS in Buenos Aires, Argentina","volume":"37","author":"Laufer","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.endinu.2019.04.012_bib0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4254\/wjh.v8.i2.83","article-title":"Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment","volume":"8","author":"Pastore","year":"2016","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.endinu.2019.04.012_bib0170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0168-8278(05)80124-2","article-title":"Latent autoimmune thyroid disease in patients with chronic HCV hepatitis","volume":"16","author":"Pateron","year":"1992","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.endinu.2019.04.012_bib0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2006.16.563","article-title":"Thyroid disorders in chronic hepatitis C virus infection","volume":"16","author":"Antonelli","year":"2006","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.endinu.2019.04.012_bib0180","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4254\/wjh.v7.i8.1074","article-title":"Autoantibodies in chronic hepatitis C: a clinical perspective","volume":"7","author":"Narciso-Schiavon","year":"2015","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.endinu.2019.04.012_bib0185","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1590\/S0004-27302013000600007","article-title":"Evaluation of thyroid function and autoimmunity in HIV-infected women","volume":"57","author":"Goncalves de Carvalho","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.endinu.2019.04.012_bib0190","first-page":"9","article-title":"Prevalence and influencing factors of thyroid dysfunction in HIV-infected patients","author":"Ji","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.endinu.2019.04.012_bib0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-1293.2007.00422.x","article-title":"No association between HIV disease and its treatment and thyroid function","volume":"8","author":"Madge","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.endinu.2019.04.012_bib0200","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/519978","article-title":"Thyroid function abnormalities in HIV-infected patients","volume":"45","author":"Hoffmann","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.endinu.2019.04.012_bib0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S1413-86702011000400013","article-title":"Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy","volume":"15","author":"Andrade","year":"2011","journal-title":"Braz J Infect Dis"},{"issue":"3","key":"10.1016\/j.endinu.2019.04.012_bib0210","first-page":"213","article-title":"Thyroid alterations following treatment with pegylated interferon and ribavirin: differences between HIV-coinfected and non-coinfected patients","volume":"24","author":"Montes-Ram\u00edrez","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.endinu.2019.04.012_bib0215","unstructured":"RSR Technical Information. \u201cTHYROID PEROXIDASE (TPO) AUTOANTIBODY RIA KIT\u201d. Available at: http:\/\/www.rsrltd.com\/tech-info.html. 2014."},{"issue":"4","key":"10.1016\/j.endinu.2019.04.012_bib0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"Perspectives in clinical hepatology. The clinical and physiological spectrum of interferon- alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"year":"2000","series-title":"Hashimoto's thyroiditis","author":"Akamizu","key":"10.1016\/j.endinu.2019.04.012_bib0225"},{"issue":"3","key":"10.1016\/j.endinu.2019.04.012_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/qjmed\/hcp157","article-title":"The swinging thyroid in hepatitis C infection and interferon therapy","volume":"103","author":"Tran","year":"2010","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.endinu.2019.04.012_bib0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","article-title":"Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection","volume":"11","author":"Zignego","year":"2015","journal-title":"Exp Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.endinu.2019.04.012_bib0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpendmet1027","article-title":"Endocrine manifestations of hepatitis C virus infection","volume":"5","author":"Antonelli","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.endinu.2019.04.012_bib0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15403\/jgld.2014.1121.252.chc","article-title":"Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis","volume":"25","author":"Shen","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"10.1016\/j.endinu.2019.04.012_bib0250","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1478-3231.2005.01159.x","article-title":"Hepatitis C-associated autoimmunity in patients coinfected with HIV","volume":"25","author":"Woitas","year":"2005","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.endinu.2019.04.012_bib0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2006.02472.x","article-title":"Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study","volume":"64","author":"Madeddu","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"15","key":"10.1016\/j.endinu.2019.04.012_bib0260","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001954","article-title":"No evidence of increased risk of thyroid dysfunction in well treated people living with HIV","volume":"32","author":"Harsl\u00f8f","year":"2018","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.endinu.2019.04.012_bib0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-008-9038-y","article-title":"Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model","volume":"19","author":"Harach","year":"2008","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.endinu.2019.04.012_bib0270","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH T4 and thyroid antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8438","key":"10.1016\/j.endinu.2019.04.012_bib0275","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(85)92475-4","article-title":"Primary hypothyroidism associated with interferon therapy of breast cancer","volume":"1","author":"Fentiman","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.endinu.2019.04.012_bib0280","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-\u03b1 and autoimmune thyroid disease","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.endinu.2019.04.012_bib0285","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4158\/EP14561.OR","article-title":"The absence of thyroid disease in an Australian hepatitis C cohort treated with triple combination therapy: a paradigm shift","volume":"21","author":"Tran","year":"2015","journal-title":"Endocr Pr"},{"issue":"6","key":"10.1016\/j.endinu.2019.04.012_bib0290","first-page":"1","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.endinu.2019.04.012_bib0295","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/thy.2012.0507","article-title":"Virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis","volume":"23","author":"Blackard","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.endinu.2019.04.012_bib0300","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3904\/kjim.2015.30.6.792","article-title":"Incidence of and risk factors for thyroid dysfunction during peginterferon \u03b1 and ribavirin treatment in patients with chronic hepatitis C","volume":"30","author":"Hwang","year":"2015","journal-title":"Korean J Intern Med"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419301442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419301442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:06:00Z","timestamp":1762866360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016419301442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2530016419301442"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2019.04.012","relation":{},"ISSN":["2530-0164"],"issn-type":[{"type":"print","value":"2530-0164"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV\u2013HIV co-infected patients before and after interferon alpha therapy: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}